Seroprevalence of Neutralizing Antibodies against Human Adenovirus Type-5 and Chimpanzee Adenovirus Type-68 in Cancer Patients

Since the preclinical results about chimpanzee adenovirus serotype-68 (AdC68)-based vaccine showed an encouraging results, it reminded us that AdC68 may be a suitable cancer vaccine vector. Previous study indicated that the seroprevalence of neutralizing antibodies (NAbs) against adenovirus was diff...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Hua, Xu, Can, Luo, Xiaoli, Wei, Feng, Wang, Ning, Shi, Huiying, Ren, Xiubao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5845880/
https://www.ncbi.nlm.nih.gov/pubmed/29563911
http://dx.doi.org/10.3389/fimmu.2018.00335

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5845880/
https://www.ncbi.nlm.nih.gov/pubmed/29563911
http://dx.doi.org/10.3389/fimmu.2018.00335

Ejemplares similares